FDA: antique of ’93 [Regulatives / Guidelines]

posted by jag009  – NJ, 2013-12-11 23:16 (2547 d 08:26 ago) – Posting: # 12041
Views: 8,247

Hi Helmut!

» So far? Unbelievable. Ask your legal department to get refund from the FDA for the study you performed exactly following the guidance only to get from SAS: WARNING: Did not converge...

They don't give refund... The govt just went through "sequester" this year... :-|

Also it was a pilot study.

Strangely, I emailed FDA about stability and they replied back the next day!
Very responsive from that group!

John

Complete thread:

Activity
 Admin contact
21,226 posts in 4,427 threads, 1,482 registered users;
online 17 (1 registered, 16 guests [including 13 identified bots]).
Forum time: Wednesday 07:42 CET (Europe/Vienna)

A big data-analyst is an expert
in producing misleading conclusions from huge datasets.
It is much more efficient to use a statistician,
who can do the same with small ones.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5